Use of non-OECD MAD non-clinical data in support of UK clinical trial authorisation applications

Imported from official source

Alert

Safety Classified by Officially

The Organisation for Economic Co-operation and Development (OECD) Mutual Acceptance of Data (MAD) framework, underpinned by the principles of good laboratory practice (GLP), remains the internationally recognised standard for the generation and regulatory acceptance of pivotal non-clinical safety data. Data generated within the OECD MAD framework benefit from established compliance monitoring programmes and provide a high level of regulatory confidence for decision-making.

The MHRA recognises that the increasingly global nature of non-clinical drug development has led to greater use of specialist test facilities generating non-clinical data outside the OECD MAD framework. Many of these non-clinical development programmes support innovative medicines intended to address serious diseases, rare conditions, and areas of significant unmet patient need.

The MHRA is committed to supporting timely patient access to innovative medicines and enabling high-quality clinical research in the UK, while maintaining robust standards of participant protection and scientific integrity.  To support these objectives, the MHRA has established a risk-proportionate and patient-centred framework for the consideration of non-OECD MAD non-clinical data submitted in support of clinical trial authorisation (CTA) applications.

For the purposes of this guidance, “non-OECD MAD data” refers to non-clinical data that do not fall within the mandatory acceptance arrangements of the OECD mutual acceptance of data system. This includes:

  • data generated in countries that are neither OECD members nor full adherents to OECD MAD
  • data generated at test facilities or test sites that are not covered by, or whose GLP compliance status has not been verified through, a national GLP compliance monitoring programme recognised under the OECD MAD system
  • This is an extract. The publication continues at the source.

    Contains public sector information licensed under the Open Government Licence v3.0. Licence

    Read the original at the source: https://www.gov.uk/guidance/use-of-non-oecd-mad-non-clinical-data-in-support-of-uk-clinical-trial-authorisation-applications

    Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    Medicines and Healthcare products Regulatory Agency — imported from official source
    Official source
    https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
    Imported
    November 04, 2026 16:00
    Versions
    1 recorded
    Identity
    https://www.gov.uk/guidance/use-of-non-oecd-mad-non-clinical-data-in-support-of-uk-clin...

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.